CURRICULUM VITA _
Phillip Dale DeCubellis, DPM
2828 East Commercial Blvd
Ft. Lauderdale, FL 33308
Phone: 954-776-5700
E-mail: DrDecubellis@southflapodiatry.com

Updated 2005
Professional Current Positions:

1997- Present Chief Department of Podiatric Medicine & Surgery
South Beach Community Hospital & Medical Center
600 & 630 Alton Road
Miami Beach, FL. 33139 (Formally South Shore Hospital).
1997- Present

Director of the Vascular Laboratory and Wound Healing Center
South Beach Community Hospital & Medical Center
600 7 630 Alton Road
Miami Beach, FL. 33139
(Formally South Shore Hospital)

1997- Present

Director of Post Graduate Residency Training
Rotating and Orthopedic Programs
South Beach Community Hospital & Medical Center.
 600 & 630 Alton Road
Miami Beach, FL. 33139 
( Formerly South Shore Hospital)

                                              
1997- Present

Principal Investigator
Princeton Research Associates Inc.
600-630 Alton Road, PH 1005
Miami Beach, FL. 33139

                                               
1997- Present

Chief Department of Podiatric Medicine & Surgery
North Ridge Medical Center
5757 N. Dixie Hwy
Ft Lauderdale, FL. 33334

1998- Present

Medical Director
Oakridge Medical Center
1000 NE 56 Street
Ft. Lauderdale, FL. 33334

1995-Present

Staff Physician              
Northridge Medical Center
5757 Dixie Hwy
Ft.Lauderdale, Fla   33334

1994- Present

Staff  Physician
Miami Heart Institute
4701 Meridian Ave.
Miami Beach, FL. 33140

1998-Present

Staff Physician            
Mt Sinai Medical Center
 4302 Alton Road
Miami Beach, FL. 33140

                                               
Education
1979-1983 B.A. Biology
University of South Florida
Tampa, FL.
1983-1987

Degree Doctor of Podiatric Medicine (DPM)
Ohio College of Podiatric Medicine
Cleveland, OH

                                               
1986-1987 Residency
University of Southern California
Director Howard Marshall, DPM
LA County Medical Center
Los Angeles, CA
1996- 1997

Fellowship.     
Podiatric Medicine & Surgery
Director: Scott A Alter, DPM
South Shore Hospital & Medical Center                                     
600 & 630 Alton Road
Miami Beach, FL, 33139

Teaching Post
1997 – Present

Director of Post – Graduate Residency Program
South Beach Community Hospital & Medical Center
(Formally South Shore Hospital & Medical Center)
600 & 630 Alton Road
Miami Beach, FL, 33139

1997 – Present

Director of Vascular Laboratory & Wound Healing Center.
South Beach Community Hospital & Medical Center
600 & 630 Alton Road
Miami Beach, FL. 33139

                                               
1994-1997

Post Graduate Residency Selection Community.
Residency Education:
Miami Heart Institute PSR-12
4701 Meridian Ave.,
Miami Beach, FL, 33140

                                               
1994- Present

Adjunct Faculty, Clinical Faculty Appointment.                               
Barry University School of Podiatric Medicine
Post- Graduate Residency Training Program
Miami Beach, FL, 33140

1996 – Present

Clinical Faculty Appointment.
New York College of Podiatric Medicine
53E 124th Street
New York, NY 10035

Board Certifications
1993- Present

Diplomat American Board of Podiatric Orthopedics, ( Life Time Certification).

1990- Present Diplomat, American Council of Podiatric Physicians & Surgeons.
1998- Present: Board Certified, Wound Care Specialist,   (CWS) American Academy of Wound Management.
Professional Memberships
Present American Podiatric Medical Association.
Present

Florida Podiatric Medical Association.

State Licenses
Active: 1988 Ohio - # 2546
Active: 1987 Illinois # 016-004213
Active:1988 Florida # PO0001934
Active:1995 Wyoming # 101
Clinical Academic Research Experience

Wound Care Treatment- Hyperbaric Oxygen Therapy Case Study- Selected Problem Wounds.,
 Phillip DeCubellis, DPM, Georgina beard, RN, CWS, Rebecca Guttermuth, RN, CWS, South Shore Hospital, Miami Beach. (1997) BioCore Medical Technologies, Inc.

 

The Use of Medifil Particles on a Non- Compliant Diabetic Neuropathic Patient with Bilateral Planter Ulcers.,Phillip DeCubellis, DPM, Georgina beard, RN, CWS, Rebecca Guttermuth, RN, CWS, South Shore Hospital, Miami Beach, FL. ( 1998) BioCore Medical Technologies, Inc.

 

The Use of Medifil Particles on a Diabetic Neuropathic Patient with Complicated Foot Ulcers.,
Phillip DeCubellis, DPM, Georgina beard, RN, CWS, Rebecca Guttermuth, RN, CWS, South Shore Hospital, Miami Beach. ( 1998) BioCore Medical Technologies, Inc.

 

The Use of Medifil Particles on a Diabetic Neuropathic Patient with Exposed Calcaneus Wounds. Phillip DeCubellis, DPM, Georgina beard, RN,CWS, Rebecca Guttermuth, RN, CWS, South Shore Hospital, Miami Beach. ( 1998) BioCore Medical Technologies, Inc.

Poster Presentation

April 18-22,1998

The 11th Annual Symposium on “Advanced Wound Care”, and 8th Annual Medical Research Forum on Wound Repair.

Clinical Research Experience

Principal Investigator

8-2000- 10-2001

Wyeth- Ayerst Pharmaceuticals Inc.
Protocol: 0910X-100468
Phase 2 ( Zosyn)
Title: An Open Label, Randomized, Study Comparing the Efficacy and Safety of Piperacillin / Tazobactam and Ampicillin / Sulbactam Administered Intravenously in the Empirical Treatment of Foot Infections in Diabetic Inpatients.

04-2001-8-2001

UCB Pharmaceuticals
Protocol: G01001-G01002
Phase 2 ( Lortab)
Title: A Multicenter, Double- Blind, Randomized, Parallel Group, Two – Period Study to Evaluate the Efficacy and Safety of Oral Doses of Extended- release Combination of Hydrocodone 15mg and Acetaminophen 1000mg (Lortab XR), Extended- release Hydrocodone 15mg, Extended Release Acetaminophen 1000mg, and Placebo in the Treatment of Moderate to Sever Pain in Subjects Undergoing Orthopedic Surgery.

05-01-01-04-10-03

Organogenesis / Norvartis
Protocol: CGSO769B US08
(Apligraf) Phase 3
Prospective Multicenter, Open Label Study To Evaluate the Efficacy and Safety of Apligraf in the Treatment of Diabetic Neuropathic Foot Ulcers That Have Not Adequately Responded to Standard Treatment.
Present: 06-2005

Arpida Pharmaceuticals:
Protocol: ICLA-08-CS11
Phase 3
Randomized, Investigational – Blind, Multi- Center Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Intravenous Linezolid in Complicated Skin and Skin Structure Infection.

Present: 2005

RegeneRX Biopharmaceuticals:
Protocol: SSPU
Phase 2A
A Randomized, Double – Blind, Placebo- Controlled, Dose- response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Pressure Ulcers.

Present: Fall 2005

F. Hoffman –La Roche Ltd.
Protocol: WI18274
Phase 2
A Phase 11 Prospective, Open- Label, Randomized, Active- Controlled, Parallel Group, Multicenter, “Proof of Concept” Trial in Adult Patients with Complicated Skin and Skin Structure Infections requiring Hospitalization.

Private Practice Experience

1990-Present

Founder: “ South Florida Podiatry Group”
Four member group of same specialty podiatric physicians with three service locations in the South Florida region.Adminstrative duties to include contracts, HMO,PPO and workers Comp as well as administrative and management duties of  the day to day operations.

1997-Present

Medical Executive Committee Member South Shore Hospital

1999-Present

Medical Executive Committee Member
Oakridge Medical Center

 

Ankle, Foot & Wound Care Associates
Phillip D. DeCubellis, D.P.M., P.A.
2828 E. Commercial Blvd
Fort Lauderdale, FL 33308
3800 North Miami Ave
Miami, FL 33127
John Knox Village Blvd, Pompano Beach, FL 33060
East Broward
West Broward
957-776-5700
957-382-1333
786-276-8987
954-776-5700

 

Home | About Us | Directions

South Florida Podiatry Group
www.southflapodiatry.com
Philip DeCubellis: drdecubellis@southflapodiatry.com
Frank Busillo: drbusillo@southflapodiatry.com
Jason Evans: drevans@southflapodiatry.com
Leon Perlstein: drperlstein@southflapodiatry.com